A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06506916 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06506916
- Sponsor
- UCB Biopharma SRL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2027-03-09
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.